Colorectal cancer screening with fecal occult blood test: A 22-year cohort study

被引:14
作者
Jin, Peng [1 ,2 ]
Wu, Zi-Tao [1 ]
Li, Shi-Rong [1 ]
Li, Shu-Jun [1 ]
Wang, Ji-Heng [1 ]
Wang, Zhi-Hong [1 ]
Lu, Jian-Guo [1 ]
Cui, Xin-Juan [1 ]
Han, Ying [1 ]
Rao, Jianyu [3 ,4 ]
Sheng, Jian-Qiu [1 ]
机构
[1] Beijing Mil Gen Hosp, Dept Gastroenterol, Beijing 100700, Peoples R China
[2] Third Mil Med Univ, Chongqing 400038, Peoples R China
[3] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90015 USA
[4] Univ Calif Los Angeles, Dept Epidemiol, Sch Publ Hlth, Los Angeles, CA 90015 USA
关键词
colorectal cancer; screening; fecal occult blood test; POPULATION; MULTICENTER;
D O I
10.3892/ol.2013.1402
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate the efficacy of colorectal cancer (CRC) screening with a three-tier fecal occult blood test (FOBT) in the Chinese population. The study was performed between 1987 and 2008 at the Beijing Military General Hospital, in a cohort of army service males and females aged >50 years. Between 1987 and 2005, a three-tier screening program, comprising guaiac-based FOBTs (gFOBTs), followed by immunochemical FOBTs for positive guaiac test samples and then colonoscopy for positive immunochemical test subjects, was performed annually. The cohort was followed up until 2008. The cohort included 5,104 subjects, of which, 3,863 subjects participated in screening (screening group) and 1,241 did not (non-screening group). The two groups did not differ in age, gender or other major risk factors for colon cancer. Overall, 36 CRCs occurred in the screening group and 21 in the non-screening group. Compared with the non-screening group, the relative risk for the incidence and mortality of CRC was 0.51 [95% confidence interval (CI), 0.30-0.87] and 0.36 (95% CI, 0.18-0.71), respectively, in the screening group. The general sensitivity of this three-tier FOBT was 80.6% (95% CI, 65.3-91.1). Thus, annual screening using the three-tier FOBT program may reduce the CRC incidence and mortality rate.
引用
收藏
页码:576 / 582
页数:7
相关论文
共 16 条
[1]   Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics [J].
Allison, James E. ;
Sakoda, Lori C. ;
Levin, Theodore R. ;
Tucker, Jo P. ;
Tekawa, Irene S. ;
Cuff, Thomas ;
Pauly, Mary Pat ;
Shlager, Lyle ;
Palitz, Albert M. ;
Zhao, Wei K. ;
Schwartz, J. Sanford ;
Ransohoff, David F. ;
Selby, Joseph V. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19) :1462-1470
[2]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[3]   Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Dietrich, Allen J. ;
Gregory, Kimberly D. ;
Harris, Russell ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Roseanne M. ;
Loveland-Cherry, Carol ;
Marion, Lucy N. ;
Melnyk, Bernadette ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Yawn, Barbara P. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (09) :627-+
[4]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[5]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471
[6]   Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: A prospective cohort study in Japan [J].
Lee, Kyung-Jae ;
Inoue, Manami ;
Otani, Tetsuya ;
Iwasaki, Motoki ;
Sasazuki, Shizuka ;
Tsugane, Shoichiro .
CANCER DETECTION AND PREVENTION, 2007, 31 (01) :3-11
[7]   Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology [J].
Levin, Bernard ;
Lieberman, David A. ;
McFarland, Beth ;
Andrews, Kimberly S. ;
Brooks, Durado ;
Bond, John ;
Dash, Chiranjeev ;
Giardiello, Francis M. ;
Glick, Seth ;
Johnson, David ;
Johnson, C. Daniel ;
Levin, Theodore R. ;
Pickhardt, Perry J. ;
Rex, Douglas K. ;
Smith, Robert A. ;
Thorson, Alan ;
Winawer, Sidney J. .
GASTROENTEROLOGY, 2008, 134 (05) :1570-1595
[8]   New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: Results of a prospective multicenter study in Chinese patients [J].
Li, Shirong ;
Wang, Huahong ;
Hu, Jichun ;
Li, Nan ;
Liu, Yulan ;
Wu, Zitao ;
Zheng, Yue ;
Wang, Honghua ;
Wu, Kai ;
Ye, Hui ;
Rao, Jianyu .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) :3078-3083
[9]  
Li SR, 2003, CHINESE MED J-PEKING, V116, P200
[10]   The effect of fecal occult-blood screening on the incidence of colorectal cancer [J].
Mandel, JS ;
Church, TR ;
Bond, JH ;
Ederer, F ;
Geisser, MS ;
Mongin, SJ ;
Snover, DC ;
Schuman, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1603-1607